News

Enceph-IG Trial - care centres needed
12 September 2023
Enceph-IG Trial: Intravenous Immunoglobulin (IVIG) in Autoimmune Encephalitis in Adults –A Randomised Double-Blind Placebo-Controlled Trial Can you help? Researchers are seeking secondary or tertiary care centres to help a trial establish whether with intravenous immunoglobulin improves recovery in adults with autoimmune encephalitis. Enceph-IG is a phase III, double blind, randomised placebo control trial lead by […]
Read More